- Home
- XBIT vs RDZN Comparison
XBIT vs RDZN Comparison
Compare XBIT & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- RDZN
- Stock Information
- Founded
- XBIT 2005
- RDZN 2015
- Country
- XBIT United States
- RDZN United States
- Employees
- XBIT 90
- RDZN N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- RDZN Blank Checks
- Sector
- XBIT Health Care
- RDZN Finance
- Exchange
- XBIT Nasdaq
- RDZN Nasdaq
- Market Cap
- XBIT 93.0M
- RDZN 79.4M
- IPO Year
- XBIT 2015
- RDZN N/A
- Fundamental
- Price
- XBIT $2.83
- RDZN $1.00
- Analyst Decision
- XBIT
- RDZN Strong Buy
- Analyst Count
- XBIT 0
- RDZN 2
- Target Price
- XBIT N/A
- RDZN $5.00
- AVG Volume (30 Days)
- XBIT 184.6K
- RDZN 681.5K
- Earning Date
- XBIT 08-11-2025
- RDZN 08-12-2025
- Dividend Yield
- XBIT N/A
- RDZN N/A
- EPS Growth
- XBIT N/A
- RDZN N/A
- EPS
- XBIT N/A
- RDZN N/A
- Revenue
- XBIT N/A
- RDZN $44,296,098.00
- Revenue This Year
- XBIT N/A
- RDZN $39.09
- Revenue Next Year
- XBIT N/A
- RDZN $65.61
- P/E Ratio
- XBIT N/A
- RDZN N/A
- Revenue Growth
- XBIT N/A
- RDZN N/A
- 52 Week Low
- XBIT $2.50
- RDZN $0.68
- 52 Week High
- XBIT $8.32
- RDZN $2.99
- Technical
- Relative Strength Index (RSI)
- XBIT 46.44
- RDZN 48.19
- Support Level
- XBIT $2.95
- RDZN $0.98
- Resistance Level
- XBIT $3.32
- RDZN $1.07
- Average True Range (ATR)
- XBIT 0.17
- RDZN 0.09
- MACD
- XBIT 0.01
- RDZN -0.00
- Stochastic Oscillator
- XBIT 40.24
- RDZN 26.67
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.